• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Deflazacort

Deflazacort

Product ID D1624
Cas No. 14484-47-0
Purity ≥98%
Product Unit SizeCostQuantityStock
25 mg $57.20 In stock
100 mg $98.60 In stock
250 mg $225.30 In stock
1 g $563.60 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Deflazacort is an oxazoline glucocorticoid clinically used to treat Duchenne muscular dystrophy; it improves motor function and slows progression of the disease. Deflazacort also exhibits anti-fibrotic activity, slowing the progression of myocardial fibrosis in dystrophin-deficient animal models.

Product Info

Cas No.

14484-47-0

Purity

≥98%

Formula

C25H31NO6

Formula Wt.

441.52

IUPAC Name

[2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,14,17-trien-8-yl]-2-oxoethyl] acetate

Melting Point

252-258°C

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

D1624 MSDS PDF

Info Sheet

D1624 Info Sheet PDF

References

Hoffman EP, Reeves E, Damsker J, et al. Novel approaches to corticosteroid treatment in Duchenne muscular dystrophy. Phys Med Rehabil Clin N Am. 2012 Nov;23(4):821-8. PMID: 23137739.

Silva EC, Machado DL, Resende MB, et al. Motor function measure scale, steroid therapy and patients with Duchenne muscular dystrophy. Arq Neuropsiquiatr. 2012 Mar;70(3):191-5. PMID: 22392111.

Joshi N, Rajeshwari K. Deflazacort. J Postgrad Med. 2009 Oct-Dec;55(4):296-300. PMID: 20083885.

Marques MJ, Oggiam DS, Barbin IC, et al. Long-term therapy with deflazacort decreases myocardial fibrosis in mdx mice. Muscle Nerve. 2009 Sep;40(3):466-8. PMID: 19623634.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • C1668

    Cerivastatin Sodium

    Statin; HMG-CoA reductase inhibitor.

    ≥98%
  • G7443

    GSK-429286A

    ROCK1/2 inhibitor, potential RSK and p70S6K inh...

    ≥98%
  • C760001

    CT-7001

    CDK7 inhibitor

    ≥99%
  • T2668

    TGR5 Receptor Agonist

    TGR5 agonist.

    ≥99%
  • E8657

    Evodiamine

    Indole alkaloid found in Evodia rutaecarpa; top...

    ≥98%
  • V3345

    Vildagliptin

    DPP4 inhibitor.

    ≥98%
  • C9809

    Cyclopiazonic Acid

    SERCA inhibitor.

    ≥98%, TLC
  • X4402

    XL-147

    Dual inhibitor of PI3K and mTOR.

    ≥98%
  • T4800

    TM3-0089 Sodium Monohydrate

    CRTH2 inhibitor.

    ≥98%
  • D0005

    Dabrafenib Mesylate

    B-Raf and c-Raf inhibitor.

    ≥98%
  • Z0146

    Z-Ala-Ala-Leu-pNA

    Proteinase subtrate.

    ≥95%
  • P5745

    Polygalic Acid

    Saponin found in Polygala.

    ≥97%
  • O9256

    16-Oxocafestol

    Synthetic cafestol derivative.

    ≥97%
  • F1607

    Febuxostat

    Xanthine oxidase inhibitor.

    ≥98%
  • O4400

    Olanzapine

    AMPK activator, D1-4, 5-HT1A/2/3/6/7, M1-5 mACh...

    ≥99%
  • T6935

    Trimebutine Base

    BK K+ channel and L-type Ca2+ channel blocker.<...

    ≥97%
  • T6811

    Tranexamic Acid

    Plasminogen inhibitor.

    ≥98%
  • G337543

    Ginsenoside CK

    Major metabolite of ginsenosides Rb1, Rb2, Rc, ...

    ≥98%
  • R5700

    Ro 61-8048

    Kynurenine 3-hydroxylase inhibitor.

    ≥99%
  • N0114

    Nadifloxacin

    Fluoroquinolone; bacterial DNA gyrase inhibitor...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only